BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

LD-2 disclosure · 2nd Quarter - Report

ALIGOS THERAPEUTICS, INC.

via WILMER CUTLER PICKERING HALE AND DORR LLP

2nd Quarter (Apr 1 - June 30) · 2023Posted Jul 21, 2023Filing document ↗LDA record ↗

Income$110Kfee reported

Client

Name: ALIGOS THERAPEUTICS, INC.
Description: biopharmaceutical company
Location: California · United States of America

Registrant

Firm: WILMER CUTLER PICKERING HALE AND DORR LLP
Description: law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Labor Issues/Antitrust/Workplace
Competition issues
LobbyistsBRIAN SKRETNY · mr JONATHAN RAPHAEL YAROWSKY
Covered position (BRIAN SKRETNY): Senior Professional Staff HFAC 2014-2021; LD Rep. Engel2014-2021; LD/Counsel Rep. Engel 2007-2012
Covered position (mr JONATHAN RAPHAEL YAROWSKY): GCHouseJudCom82-95; SACPres95-98
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ALIGOS THERAPEUTICS, INC. — Lobbying — Receipts Report